Callos Andrew bought CYTK
August 31, 2026 · Form 4 insider transaction
Callos Andrew bought 10,000 shares of Cytokinetics, Incorporated at $23.26 per share, a transaction worth $232.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$23.26
Total value
$232.6K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 31, 2026
Filing dateAugust 31, 2026
Shares owned after68,555
OwnershipDirect
10b5-1 planNo
AmendedNo